Treating metastatic pancreatic ductal adenocarcinoma: NALIRIFOX as new standard? Besselink MG, Wilmink JW. Lancet 2023 Sep 11:S0140-6736(23)01521-0. doi: 10.1016/S0140-6736(23)01521.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Besselink MG, Wilmink JW. Treating metastatic pancreatic ductal adenocarcinoma: NALIRIFOX as new standard? Lancet 2023 Sep 11:S0140-6736(23)01521-0. doi: 10.1016/S0140-6736(23)01521.
PMID: 37708905